Enanta Pharmaceuticals Inc. | Cash Flow
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,627.00
34,438.00
78,992.00
21,666.00
17,710.00
71,956
Depreciation, Depletion & Amortization
221.00
352.00
639.00
1,661.00
2,137.00
2,518
Other Funds
-
110.00
1,814.00
1,026.00
11.00
14,675
Funds from Operations
9,912.00
22,437.00
93,503.00
29,638.00
30,683.00
91,007
Changes in Working Capital
741.00
2,258.00
16,830.00
6,171.00
21,970.00
61,787
Net Operating Cash Flow
10,653.00
20,179.00
76,673.00
35,809.00
52,653.00
29,220
Capital Expenditures
606.00
1,028.00
2,336.00
4,738.00
2,506.00
Sale of Fixed Assets & Businesses
-
3.00
9.00
-
-
Purchase/Sale of Investments
68,610.00
1,522.00
85,687.00
38,925.00
2,066.00
Net Investing Cash Flow
69,216.00
497.00
88,186.00
43,663.00
4,572.00
Issuance/Reduction of Debt, Net
-
-
-
68.00
73.00
Net Financing Cash Flow
56,911.00
1,164.00
2,540.00
2,705.00
1,017.00
Net Change in Cash
1,652.00
21,840.00
8,973.00
5,149.00
49,098.00
Free Cash Flow
10,047.00
19,151.00
74,337.00
31,071.00
50,147.00
Deferred Taxes & Investment Tax Credit
-
-
-
2,294.00
1,654.00
1,858
Change in Capital Stock
56,911.00
1,054.00
726.00
1,747.00
1,079.00
Other Uses
-
-
172.00
-
-
About Enanta Pharmaceuticals
View Profile
